Suppr超能文献

改善大疱性类天疱疮预后的策略:临床表现、诊断及患者评估的全面综述

Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients' Assessment.

作者信息

Ruggiero Angelo, Megna Matteo, Villani Alessia, Comune Rosita, Fabbrocini Gabriella, di Vico Francesca

机构信息

Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, 80131, Italy.

Section of Radiology and Radiotherapy, Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, 80138, Italy.

出版信息

Clin Cosmet Investig Dermatol. 2022 Apr 14;15:661-673. doi: 10.2147/CCID.S267573. eCollection 2022.

Abstract

Bullous pemphigoid (BP) is the most frequent autoimmune bullous disease mainly affecting elderlies. Diagnosis usually results from clinical features, histological examination, and the quantification of circulating typical autoantibodies, due to its higher incidence in elderly patients, bullous pemphigoid treatment and management still represents a challenge due to the higher frequency of several comorbidities in this group of patients, which may also be linked to a reduced tolerance to BP treatments. Hence, an early diagnosis and a prompt correct treatment are mandatory to reach better clinical outcomes and improve as much as possible BP outcomes. Herein, we carried out a comprehensive literature review about the known clinical presentations, diagnosis, assessment and monitoring procedures used in daily clinical practice in patients with BP, to better define strategies to improve as much as possible BP clinical outcomes.

摘要

大疱性类天疱疮(BP)是最常见的自身免疫性大疱性疾病,主要影响老年人。诊断通常基于临床特征、组织学检查以及循环中典型自身抗体的定量检测。由于老年患者中其发病率较高,大疱性类天疱疮的治疗和管理仍然是一项挑战,因为该组患者中多种合并症的发生率较高,这也可能与对BP治疗的耐受性降低有关。因此,早期诊断和及时正确的治疗对于获得更好的临床结局以及尽可能改善BP的预后是必不可少的。在此,我们对BP患者日常临床实践中使用的已知临床表现、诊断、评估和监测程序进行了全面的文献综述,以更好地确定尽可能改善BP临床结局的策略。

相似文献

1
Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients' Assessment.
Clin Cosmet Investig Dermatol. 2022 Apr 14;15:661-673. doi: 10.2147/CCID.S267573. eCollection 2022.
2
Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.
Acta Dermatovenerol Croat. 2017 Oct;25(3):255-256.
3
Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.
Br J Dermatol. 2009 Oct;161(4):861-8. doi: 10.1111/j.1365-2133.2009.09300.x. Epub 2009 May 8.
4
Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
Clin Rev Allergy Immunol. 2018 Feb;54(1):26-51. doi: 10.1007/s12016-017-8633-4.
5
Bullous pemphigoid.
Autoimmun Rev. 2017 May;16(5):445-455. doi: 10.1016/j.autrev.2017.03.010. Epub 2017 Mar 8.
6
Non-Bullous Pemphigoid: A Single-Center Retrospective Study.
Dermatology. 2021;237(6):1039-1045. doi: 10.1159/000515954. Epub 2021 May 12.

引用本文的文献

1
2
Patient Experiences of Bullous Pemphigoid: Symptoms and Health-Related Quality of Life Impacts.
Dermatol Ther (Heidelb). 2025 May 14. doi: 10.1007/s13555-025-01424-z.
4
Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid.
Front Oncol. 2023 Mar 3;13:1095694. doi: 10.3389/fonc.2023.1095694. eCollection 2023.
6
Association between bullous pemphigoid and atopic dermatitis: a population-based case-control study in Taiwan.
Arch Dermatol Res. 2023 Apr;315(3):419-427. doi: 10.1007/s00403-022-02372-w. Epub 2022 Jul 14.

本文引用的文献

1
Concomitant bullous pemphigoid and palmoplantar keratoderma: A report of three cases and review of literature.
Dermatol Ther. 2020 Nov;33(6):e14481. doi: 10.1111/dth.14481. Epub 2020 Nov 9.
2
Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis.
JAAD Case Rep. 2020 Apr 29;6(5):400-402. doi: 10.1016/j.jdcr.2020.03.003. eCollection 2020 May.
3
Bullous pemphigoid with linear lesions and antibodies exclusively against the soluble ectodomain of BP180 (LAD-1).
J Dtsch Dermatol Ges. 2019 Sep;17(9):933-935. doi: 10.1111/ddg.13898. Epub 2019 Jul 28.
4
Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering.
Front Immunol. 2019 Jul 2;10:1389. doi: 10.3389/fimmu.2019.01389. eCollection 2019.
5
Bullous pemphigoid.
An Bras Dermatol. 2019 Mar-Apr;94(2):133-146. doi: 10.1590/abd1806-4841.20199007. Epub 2019 May 9.
6
A new indirect immunofluorescence BIOCHIP method for the serological diagnosis of bullous pemphigoid: A review of literature.
Australas J Dermatol. 2019 Aug;60(3):e173-e177. doi: 10.1111/ajd.13034. Epub 2019 Apr 9.
7
A new clinical variant of acquired reactive perforating dermatosis-like bullous pemphigoid.
Br J Dermatol. 2019 Jan;180(1):231-232. doi: 10.1111/bjd.17146. Epub 2018 Nov 13.
9
Nonbullous pemphigoid: A systematic review.
J Am Acad Dermatol. 2018 May;78(5):989-995.e2. doi: 10.1016/j.jaad.2017.10.035. Epub 2017 Nov 1.
10
Bullous pemphigoid.
Autoimmun Rev. 2017 May;16(5):445-455. doi: 10.1016/j.autrev.2017.03.010. Epub 2017 Mar 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验